Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000080255-25-000162
Filing Date
2025-02-07
Accepted
2025-02-07 11:55:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5840
  Complete submission text file 0000080255-25-000162.txt   7678
Mailing Address P.O. BOX 89000 BALTIMORE MD 21289
Business Address 100 EAST PRATT ST BALTIMORE MD 21202 (410)345-2000
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by) CIK: 0000080255 (see all company filings)

EIN.: 520556948 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6200 Security & Commodity Brokers, Dealers, Exchanges & Services
(CF Office: 09 Crypto Assets)

Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Subject) CIK: 0001496323 (see all company filings)

EIN.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91132 | Film No.: 25600287
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)